Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinorelbine vs Paclitaxel with Epirubicin in TEKT4-Variant Breast Cancer
NCT02628613Phase 2Completed
- Sponsor
- Fudan University
- Start
- Dec 2015
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vinorelbine in breast cancer, sponsored by Fudan University. Started Dec 2015; status: completed.
02
Drugs
vinorelbine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02628613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02628613.